Related Experiment Video
Updated: May 21, 2026

09:17
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Hypoxia-inducible factor-1 alpha in the heart: a double agent?
Satwat Hashmi1, Suhail Al-Salam
1Department of Pathology, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Cardiology in Review
|June 8, 2012
Summary
Hypoxia-inducible factor-1α (HIF-1α) plays a dual role in heart disease, offering protection in acute ischemia but potentially causing harm in chronic conditions. Its activation
Area of Science:
- Cardiovascular Pathophysiology
- Molecular Biology
- Cellular Response to Hypoxia
Background:
- Hypoxia-inducible factor (HIF) regulates cellular responses to low oxygen levels.
- HIF-1α has a well-established protective role in cardiovascular disease.
- Emerging evidence suggests HIF-1α may also have maladaptive roles requiring further study.
Purpose of the Study:
- To review recent findings on HIF-1α's role in the heart.
- To explore the contrasting effects of HIF-1α in acute versus chronic ischemic heart disease.
Main Methods:
- Literature review of recent studies on HIF-1α.
- Analysis of experimental and clinical data on HIF-1α activation in cardiovascular conditions.
Main Results:
- HIF-1α activation is beneficial in acute myocardial ischemia.
- HIF-1α activation appears deleterious in chronic ischemic heart disease.
- The duration and intensity of HIF-1α activation determine its pathological or beneficial effects.
Conclusions:
- The role of HIF-1α in ischemic heart disease is complex and context-dependent.
- Understanding the nuances of HIF-1α activation is crucial for developing targeted therapies.
- Further research is needed to elucidate the precise mechanisms underlying HIF-1α's dual role.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
General Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

